Celgene Study Site

Omaha, Nebraska 68198

We've found

1 trials

at this facility

Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma

Status: Enrolling
Updated: 4/24/2017

from

Omaha, NE

Use our guide to learn which trials are right for you!